Rob Capone
InvestorPartner at Telegraph Hill Partners
Chapel Hill, North Carolina
Writes $100K β $5M checks Β· typically $1.5M
FoundedMosaicbioPanome Bio
About
Rob Capone is a Partner at THP who previously spent four years at Telegraph Hill Partners as an Associate before working ten years as a strategy consultant, most recently as a Partner at Trinity Life Sciences. He serves on the boards of Cell Microsystems and Emerging Therapy Solutions and holds a BBA from Notre Dame and an MBA from UC Berkeley's Haas School.
Invests in
BiotechMedical Devices
Experience
- Telegraph Hill PartnersPartnercurrent2021 β presentRaleigh-Durham-Chapel Hill Area
- TRINITYPartner2020 β 2021Raleigh-Durham-Chapel Hill Area
- BluePrint Research GroupPartner2017 β 2020San Francisco, California
- BluePrint Research GroupAssociate Partner2015 β 2017San Francisco Bay Area
- ZS AssociatesEngagement Manager2013 β 2015San Francisco Bay Area
- ZS AssociatesConsultant2011 β 2013San Francisco Bay Area
- ZS AssociatesSummer Associate2010
- Telegraph Hill PartnersAssociate2006 β 2009San Francisco Bay Area
- Seven Hills PartnersAnalyst2004 β 2006San Francisco Bay Area
Education
- University of California, Berkeley, Haas School of BusinessMaster of Business Administration2009 β 2011
- University of Notre DameBBA, Finance1997 β 2001
Same school
Also attended University of California, Berkeley, Haas School of Business511
+ 505 more
Also attended University of Notre Dame174
+ 168 more
Shared employers
Also worked at TRINITY6
Also worked at BluePrint Research Group2
Also worked at ZS Associates43
+ 37 more
Also worked at Telegraph Hill Partners8
+ 2 more
Deals Β· 2
Emerging Therapy SolutionsBoard seat
via Telegraph Hill Partners Β· filed Dec 2022
Cell MicrosystemsBoard seat
via Telegraph Hill Partners Β· filed Nov 2021 Β· $12.7M raise
Attribution from SEC filings, press coverage, and firm rosters.
Colleagues at Telegraph Hill Partners
Network3
Investors connected to Rob in public investor directories β a warm-intro map.




































